Latest NewLimit News & Updates

See the latest news and media coverage for NewLimit. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
NewLimit

Biotechnology company developing epigenetic reprogramming therapies

newlimit.com
Headquarters
South San Francisco, United States
Founded year
2022
Company type
Private company
Number of employees
10–60

Latest news about NewLimit

Company announcements

  • NewLimit

    NewLimit announces January-February 2026 progress

    Discovers new reprogramming payloads restoring hepatocyte functions, advances manufacturing of first candidate, builds AI system doubling discovery rate, and develops kidney endothelial model.

  • NewLimit

    NewLimit reviews 2025 reprogramming achievements

    Built first preclinical candidate restoring youthful hepatocyte functions, developed AI doubling discoveries per dollar, discovered 30+ payloads, launched vascular program.

  • NewLimit

    NewLimit optimizes hepatocyte reprogramming therapeutic

    Payload achieves 8X specificity and 1.6X potency. New payloads restore youthful resilience in liver models. Talented scientists join key teams.

  • NewLimit

    NewLimit raised an additional $45M

    The round included Lilly, Duke Management, Section 32, and Abstract on a $1.62B cap, funding advances that enable planning of clinical studies.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about NewLimit

Track NewLimit and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

NewLimit competitors & trending companies

Browse news for competitors to NewLimit and other trending companies.